An analysis of the warning letters issued by the FDA to pharmaceutical manufacturers regarding misleading health outcomes claims

OBJECTIVE: To evaluate the number and type of warning letters issued by the US Food and Drug Administration (FDA) to pharmaceutical manufacturers for promotional violations. METHODS: Two reviewers downloaded, printed and independently evaluated warning letters issued by the FDA to pharmaceutical man...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatterjee, Satabdi, Patel, Harshali K., Sansgiry, Sujit S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780498/
https://www.ncbi.nlm.nih.gov/pubmed/24155837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780498/
https://www.ncbi.nlm.nih.gov/pubmed/24155837

Ejemplares similares